Borie and coauthors reported a prevalence of 16.8% of TERT/TERC disease-associated variants in patients with familial and sporadic pulmonary fibrosis [60], while deleterious variants in TERT, RTEL1, and PARN were seen in 11.3% of IPF patients, compared to only 0.3% of controls in the study by Petrovski et al. [61]. This evidence concerns the gene TERT and pulmonary fibrosis.